Description
The rise of Novel Benzodiazepines (Benzos) pose a significant public health risk because Novel Benzos are unregulated, unpredictable and potentially more potent than prescription benzos. Sometimes Novel benzos are sold as Xanax but they often contain other drugs. This one - hour learning session will share some information regarding trends in non- prescribed use of Xanax. This session will also discuss characteristics of Xanax, complexities related to non-prescribed use of Xanax and how to manage risks within a harm reduction framework.Trainers
- VDDI: Southern Dual Diagnosis Service
Categories:
Capability 6 - Understanding and responding to substance use and addiction
Disciplines:
Allied Health,
Lived Experience Workforce,
Medical,
Nursing
Levels:
Introductory
Lifespans:
Youth,
Adult
Wednesday 22 March 2023
11:00 to 12:00 Add to calendar
11:00 to 12:00 Add to calendar
Online Mode
To register please send an email to sdds@monashhealth.org
Provided by
VDDI: Southern Dual Diagnosis Service
For further information contact